Abstract:Background: Proton minibeam radiation therapy (pMBRT) can deliver spatially fractionated dose distributions with submillimeter resolution. These dose distributions exhibit significant heterogeneity in both depth and lateral directions. Accurate characterization of pMBRT doses requires dosimetry devices with high spatial resolution and a wide dynamic range. Furthermore, the dependency of dosimetric measurements on Linear Energy Transfer (LET), as observed in conventional proton therapy, is also present in pMBRT depth dose measurements. Purpose: This work demonstrates the process of performing comprehensive dosimetric measurements to characterize the pMBRT collimator on a clinical single-gantry proton machine, utilizing commercially available dosimetry devices. Methods: The minibeam collimator is designed to be mounted on the clinical nozzle as a beam-modifying accessory. Three collimators, each with a slit opening of 0.4 mm, are thoroughly evaluated. The center-to-center (c-t-c) distances of the slits for these collimators are 2.8 mm, 3.2 mm, and 4.0 mm, respectively. High spatial resolution dosimetry devices are essential for PMBRT dose characterizations. To meet this requirement, two-dimensional (2D) dose measurement devices, Gafchromic films, are used to measure lateral profiles at various depths. Films are also used for depth dose profile measurements in solid water. Additionally, high-resolution point dose detectors, microDiamond, and Razor diode detectors are employed for lateral profile measurements at various depths. Percent depth dose (PDD) measurements of pMBRT in solid water, with various proton energies, collimators, and air gaps, are performed using Gafchromic films. The film's LET dependency for proton beams is corrected to ensure accurate pMBRT PDD measurements. The Monte Carlo simulation tool TOPAS is utilized to compare and validate all experimental measurements. Results: At depths where LET is not a concern, film dose measurements were consistent with microDiamond and Razor diode point measurements. The point detectors need to be orientated with the thin side aligned to the incoming beam. Comparison of the lateral dose profiles extracted from TOPAS simulations, films, microDiamond, and Razor diode detectors shows a passing rate exceeding 98% in 1D gamma analysis at 3% 0.1 mm criteria.However, when the microDiamond detector is orientated to face the pMBRT beam, its spatial resolution may not be sufficient to capture the peak and valley dose accurately. Nevertheless, an accuracy within 2% can still be achieved when comparing the average dose. The PDD measurements show that the peak valley dose ratio (PVDR) of pMBRT can be altered at different depths with different air gaps using the same collimator or different collimators of different c-t-c distances. Conclusion: Our study demonstrates that comprehensive dose measurements for pMBRT can be conducted using standard clinical dose measurement devices. These measurements are indispensable for guiding and ensuring accurate dose reporting in pre-clinical studies using the pMBRT technique.

Real-time gated proton therapy with a reduced source to imager distance: Commissioning and quality assurance

SU-FF-T-174: A New Device for the Verification of Temporal Function of the 4DCT and Gating Delivery System

Investigation of intra-fractionated range guided adaptive proton therapy (RGAPT): (Part II) range-shift compensated on-line treatment adaptation and verification

Comprehensive beam delivery latency evaluation for gated proton therapy system using customized multi‐channel signal acquisition platform

Repurposing DailyQA3 for an efficient and spot position sensitive daily quality assurance tool for proton therapy

Development and Performance Evaluation of a Prompt Gamma Imaging System for Real-time Proton Therapy Monitoring

Comparison of translation algorithms in determining maximum allowable CTV shifts for Real‐Time Gated Proton Therapy (RGPT) robustness evaluation in prostate cancers

Commissioning of a novel gantry-less proton therapy system

Implementation of novel measurement-based patient-specific QA for pencil beam scanning proton FLASH radiotherapy

Processing of prompt gamma-ray timing data for proton range measurements at a clinical beam delivery

Registration of On-Board X-ray Images with 4DCT: A Proposed Method of Phase and Setup Verification for Gated Radiotherapy

Characteristics of breathing-adapted gating using surface guidance for use in particle therapy: A phantom-based end-to-end test from CT simulation to dose delivery

A comprehensive pre‐clinical treatment quality assurance program using unique spot patterns for proton pencil beam scanning FLASH radiotherapy

Comprehensive dosimetric commissioning of proton minibeam radiotherapy on a single gantry proton system

Commissioning and clinical implementation of an independent dose calculation system for scanned proton beams

Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification

Su-Gg-J-148: Evaluation of Performance of A Conceptual Time-Resolved Proton Range Telescope for In-Room Respiration Monitoring Using Monte Carlo Simulations and 4dct Patient Data

Efficient EPID-based Quality Assurance of Beam Time Delay for Respiratory-Gated Radiotherapy with Validation on Catalyst™ and AlignRT™ Systems.

Efficient EPID‐based quality assurance of beam time delay for respiratory‐gated radiotherapy with validation on CatalystTM and AlignRTTM systems

Commissioning of carbon-ion radiotherapy for moving targets at the Osaka Heavy-Ion Therapy Center

Simulation Study of a 3-D Multislit Prompt Gamma Imaging System for Proton Therapy Monitoring